Rachel Szekely
Allergy & Immunology · Mentor, OHNPI 1548237431
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.8%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Genentech USA, Inc. accounts for 83.6% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $9,207 and has fallen 96.4% since, to $336 in 2025.
Across 115 payments — averaging $149.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$14K
- AstraZeneca$2K
- Pfizer$412
- CSL Behring$129
- Novartis$126
- Sanofi-aventis U.S. LLC$125
- plus $520 from 11 others
What the payments were for
- Consulting fees$2,56515%
- Speaking & faculty fees$9,62056%
- Travel & lodging$1,4508%
- Food & beverage$3,61221%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 22 | $14,420 |
| AstraZeneca | 25 | $1,516 |
| Pfizer | 31 | $412 |
| CSL Behring | 5 | $129 |
| Novartis | 6 | $126 |
| Sanofi-aventis U.S. LLC | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $119 |
| GSK | 6 | $95 |
| Regeneron Healthcare Solutions, Inc. | 3 | $86 |
| Optinose US, Inc. | 3 | $51 |
| Azurity Pharmaceuticals, Inc. | 2 | $42 |
| Merck | 2 | $38 |
| Blueprint Medicines Corporation | 1 | $21 |
| Biocryst US Sales Co., LLC | 1 | $18 |
| Hikma Pharmaceuticals USA | 1 | $18 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $18 |
| Sanofi | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XOLAIR$14,144
- BREZTRI AEROSPHERE$125
- BREZTRI$125
- SOLIQUA 100/33$125
How this compares
$17,248 in reported general payments places this provider in the 80th percentile of 128 allergy & immunology providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Montelukast Sodium | 62 | $581 |
| Azelastine Hcl | 16 | $448 |
| Levocetirizine Dihydrochloride | 22 | $275 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Mentor
- Justin GreiweCincinnati$1M
- Jonathan BernsteinCincinnati$810K
- Adam UpdegraffToledo$379K
- Syed RehmanToledo$374K
- Gordon MyersCincinnati$346K
- Nancy Wasserbauer KingstonRocky River$256K
- David LangCleveland$251K
- James FernandezCleveland$179K
- Donald McNeilColumbus$136K
- Amber PattersonFindlay$128K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.